bullish sentiment: Why Vikas Khemani has a bullish view in short, medium & long term

“We are very, very positive on the CDMO and CRO space within pharma, which we think is a very structural trend over the next 5 to 10 to 15 years. The CDMO space is a very small space right now. But what we saw in IT, we could see in the CDMO space, specific to pharma.”

Related Keywords

India ,Lucknow ,Uttar Pradesh ,Kozhikode ,Kerala ,China ,Vikas Khimani ,Vikas Khemani ,Syngene International ,Indian School Of Business ,Laurus Lab ,Offering College ,Carnelian Capital Advisors ,Leadership Excellence ,Executive Officer ,Product Officer ,Might Also Like ,Bullish Sentiment ,Market View ,Cdmo ,Laurus Lab Syngene Newland ,Economic Growth ,Expert View ,Stock Market ,Et Now ,